{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:25:34Z","timestamp":1791296734726,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.actatropica.2004.11.008","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T15:14:38Z","timestamp":1107875678000},"page":"295-301","source":"Crossref","is-referenced-by-count":26,"title":["Interleukin 10 receptor blockade\u2014pentavalent antimony treatment in experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"93","author":[{"given":"Henry W.","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2004.11.008_bib1","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/1521-4141(200010)30:10<2935::AID-IMMU2935>3.0.CO;2-Q","article-title":"Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis","volume":"30","author":"Alexander","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actatropica.2004.11.008_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1006\/cyto.2000.0694","article-title":"IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis","volume":"12","author":"Barcellar","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.actatropica.2004.11.008_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<669::AID-IMMU669>3.0.CO;2-N","article-title":"Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani","volume":"28","author":"Engwerda","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actatropica.2004.11.008_bib4","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.45.6.1872-1875.2001","article-title":"Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice","volume":"45","author":"Escobar","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2004.11.008_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin-10 production correlates with pathology in human Leishmania donovani infection","volume":"92","author":"Ghalib","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actatropica.2004.11.008_bib6","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.4049\/jimmunol.170.11.5625","article-title":"Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis","volume":"170","author":"Ghosh","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2004.11.008_bib7","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI116372","article-title":"In vivo cytokine profiles in patients with kala-azar marked elevation of both interleukin-10 and interferon-gamma","volume":"91","author":"Karp","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actatropica.2004.11.008_bib8","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/IAI.62.3.1058-1063.1994","article-title":"Induction of Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis","volume":"62","author":"Miralles","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2004.11.008_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.actatropica.2004.11.008_bib10","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.4049\/jimmunol.161.8.4153","article-title":"Blockade of CTLA-4 enhances host resistance to the intracellular pathogen Leishmania donovani","volume":"161","author":"Murphy","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2004.11.008_bib11","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actatropica.2004.11.008_bib12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/157.5.973","article-title":"Immunochemotherapy for intracellular Leishmania donovani infection: interferon-gamma plus pentavalent antimony","volume":"157","author":"Murray","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2004.11.008_bib13","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1172\/JCI114009","article-title":"Successful response to chemotherapy in experimental visceral leishmaniasis: requirement for T cells and effect of lymphokines","volume":"83","author":"Murray","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actatropica.2004.11.008_bib14","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/AAC.37.7.1504","article-title":"Treatment of experimental visceral leishmaniasis in a T cell-deficient host: response to amphotericin B and pentamidine","volume":"7","author":"Murray","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2004.11.008_bib15","first-page":"127","article-title":"Cytokines in the treatment of leishmaniasis","volume":"1","author":"Murray","year":"1994","journal-title":"Bailliere's Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2004.11.008_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.181.1.387","article-title":"Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis","volume":"181","author":"Murray","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.actatropica.2004.11.008_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1201-9712(00)90078-X","article-title":"Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches","volume":"4","author":"Murray","year":"2000","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2004.11.008_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/IAI.68.1.288-293.2000","article-title":"Role of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis","volume":"68","author":"Murray","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2004.11.008_bib19","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/315890","article-title":"Interleukin 12 regulates the response to chemotherapy in experimental visceral leishmaniasis","volume":"182","author":"Murray","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2004.11.008_bib20","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1128\/IAI.68.11.6289-6293.2000","article-title":"Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment","volume":"68","author":"Murray","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2004.11.008_bib21","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical and experimental advances in treatment in visceral leishmaniasis","volume":"45","author":"Murray","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2004.11.008_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2613.2001.00199.x","article-title":"Tissue granuloma structure-function in experimental visceral leishmaniasis","volume":"82","author":"Murray","year":"2001","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.actatropica.2004.11.008_bib23","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2004.11.008_bib24","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1128\/AAC.47.8.2513-2517.2003","article-title":"Immunoenhancement combined with amphotericin B as treatment in experimental visceral leishmaniasis","volume":"47","author":"Murray","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2004.11.008_bib25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/376510","article-title":"Determinants of response to interleukin 10 receptor blockade immunotherapy in experimental visceral leishmaniasis","volume":"188","author":"Murray","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2004.11.008_bib26","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/IAI.71.11.6453-6462.2003","article-title":"Modulation of T cell costimulation as immuno- or immunochemotherapy in experimental visceral leishmaniasis","volume":"71","author":"Murray","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2004.11.008_bib27","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/1521-4141(200003)30:3<834::AID-IMMU834>3.0.CO;2-9","article-title":"IL-12 gene-deficient C57BL\/6 mice are susceptible to Leishmania donovani but have diminished hepatic pathology","volume":"30","author":"Satoskar","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actatropica.2004.11.008_bib28","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/IAI.71.8.4804-4807.2003","article-title":"Both interleukin-4 (IL-4) and IL-4 receptor \u03b1 signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity","volume":"71","author":"Stager","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2004.11.008_bib29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4269\/ajtmh.1997.56.522","article-title":"Circulating Th1 cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis","volume":"56","author":"Sundar","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2004.11.008_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/eji.200324021","article-title":"Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani","volume":"34","author":"Zubairi","year":"2004","journal-title":"Eur. J. Immunol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X05000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X05000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T02:35:17Z","timestamp":1682994917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X05000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0001706X05000227"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2004.11.008","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}